Will the FTC rein in health data juggernaut IQVIA?; the AMA's new president on medicine's 'AI era'

An FTC lawsuit seeking to block IQVIA's acquisition of a digital advertising firm marks a crossroads for the health data giant.

July 25, 2023 Check out STAT+

Sponsored By

Adobe STAT+ | IQVIA has grown unchecked into a health data juggernaut. Will the FTC rein it in? An FTC lawsuit seeking to block IQVIA's acquisition of digital advertising firm DeepIntent marks a crossroads for the health data giant. By Casey Ross The AMA's new president on medicine's 'AI era' and the uncertain future of telehealth STAT spoke to Jesse Ehrenfeld, the new president of the American Medical Association, about medical AI, telehealth, and EHRs. By Katie Palmer STAT+ | Biogen says it will cut costs by $700 million, slash 1,000 jobs The company also released second quarter sales and earnings that handily topped the forecasts of Wall Street analysts. By Matthew Herper and Damian Garde Marion Berard/AFP/GettyImages STAT+ | As Alzheimer's drugs hit the market, the race for early detection blood tests heats up The increasing use of biomarkers in diagnostic tests is prompting neurologists to redefine Alzheimer's by biology rather than symptoms. By Brittany Trang STAT+ | Truvian presents data for its desktop blood-testing device in a field still in Theranos's shadow The results support Truvian's vision of decentralized clinical testing, but resurface questions about an approach associated with Theranos. By Jonathan Wosen STAT+ | Drug from Stoke shows lower activity against childhood epilepsy, prompting search for better dose The company is still seeking an effective dose for an experimental drug to treat a severe form of childhood epilepsy. By Adam Feuerstein Mark Wilson/Getty Images White House unveils plan to make insurers cover mental health care New rules aim to close loopholes that insurers have used to avoid covering mental health and addiction in parity with physical health. By Lev Facher Opinion: Q&A: Giving voice to patients navigating cancer, rare disease, and more Health care is about many things — treating disease, developing new drugs — but at its core, it all comes down to the patient. By Erica Goode

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser